Search results
CNS Pharmaceuticals (NASDAQ: CNSP) Announces Reverse Stock Split
Digital Journal· 4 days agoPharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain< ...
‘Frances Oldham Kelsey, the FDA, and the Battle Against Thalidomide’ Review: The Noble Bureaucrat
The Wall Street Journal· 4 days agoMost famously, it causes phocomelia, a disorder that prevents the growth of arms and legs in utero,...
POEMS Syndrome
Health via Yahoo News· 19 hours agoThe causes are unclear, but a protein called vascular endothelial growth factor (VEGF) seems to play a key role in the development of POEMS syndrome....
Hunter Biden trial enters day 5 after testimony from sister-in-law-turned-girlfriend: 'Panicked'
Fox News· 1 day agoHunter Biden’s sister-in-law-turned-girlfriend, Hallie Biden, took the stand in the first son’s...
Too Much Internet Use Is Changing Teenage Brains, Study Finds
Forbes· 4 days agoExcessive use of the internet is reshaping teenage brains, according to a new study. Scans show that...
Rapport Therapeutics Announces Pricing of Initial Public Offering - Rapport Therapeutics...
Benzinga· 2 days agoRapport Therapeutics, Inc. RAPP, a clinical-stage biotechnology company focused on discovery and development of transformational small molecule medicines for patients suffering ...
Denali's (DNLI) Candidate Selected for FDA's START Pilot Program
Zacks via Yahoo Finance· 4 days agoDenali's (DNLI) DNL126, an investigational enzyme replacement therapy, gets selected for the START...
CNS Pharmaceuticals Announces Reverse Stock Split
Digital Journal· 5 days agoThe Company's lead drug candidate, Berubicin, is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. Berubicin ...
Confusion and Cognitive Effects: What to Know
Verywell Health via Yahoo News· 2 days ago... infection (e.g., urinary tract infection) Electrolyte imbalance (e.g., hyponatremia) Very high or very low blood sugar in someone with diabetes Very...
Israeli Startup Combines Software With Medicine To Transform $1.6 Trillion Pharma Market
Forbes· 2 days agoCombining software with medicine to unlock an entire new market for “hybrid drugs” is the vision...
